Literature DB >> 8523425

Ischaemic preconditioning in a model of global ischaemia: infarct size limitation, but no reduction of stunning.

D P Jenkins1, W B Pugsley, D M Yellon.   

Abstract

It is well known that ischaemic preconditioning delays infarct size during regional ischaemic insults. However, the extent of this protective effect against different ischaemia periods has not been established, and any reduction in stunning has been difficult to demonstrate with regional models. In this study we have investigated ischaemic preconditioning in a buffer-perfused isolated rabbit heart model with a global ischaemic insult, and measured both infarct volume and functional recovery. Experiments were performed with three ischaemia time periods of 15, 20 and 30 min at 37 degrees C. Infarct volume (expressed as a percentage of left ventricular volume) was measured by tetrazolium staining after 2 hours reperfusion, and left ventricular developed pressure with an intraventricular balloon. Hearts preconditioned with 5 min ischaemia and 10 min reperfusion were compared with a control group. In this model, preconditioning resulted in a 57% reduction in infarct volume compared with control hearts (P = 0.02) subjected to 20 min of global ischaemia, but the degree of this infarct delaying effect was dependent on the ischaemia time and was only 37% (P = 0.02) and 11% (N.S.) with a 30 min and 15 min ischaemic challenge respectively. Recovery of post-ischaemic left ventricular developed pressure as a percentage of the pre-ischaemic value correlated very well with infarct volume in control r = -0.82 (P < 0.001) and preconditioned r = -0.78 (P < 0.001) groups, and the slope of the regression lines was similar for both groups. These results demonstrate that the degree of protection produced by preconditioning is not uniform but varies with the length of the ishaemic insult. By measuring both infarct volume and functional recovery we have been able to confirm that any post-ischaemic improvement in global left ventricular function produced by preconditioning is secondary to reduced infarction, and hence that preconditioning does not attenuate stunning.

Entities:  

Mesh:

Year:  1995        PMID: 8523425     DOI: 10.1016/s0022-2828(95)90590-1

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  18 in total

Review 1.  Efficacy of preconditioning should be gauged by reduction of infarction.

Authors:  Michael V Cohen
Journal:  Br J Pharmacol       Date:  2004-01       Impact factor: 8.739

Review 2.  The role of myocardial ischaemic preconditioning during beating heart surgery: biological aspect and clinical outcome.

Authors:  Efstratios Apostolakis; Nikolaos G Baikoussis; Nikolaos A Papakonstantinou
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-11-15

Review 3.  Preconditioning--a reappraisal of protection.

Authors:  L M King; L H Opie
Journal:  Basic Res Cardiol       Date:  1996 Jan-Feb       Impact factor: 17.165

4.  Preconditioning by subinotropic doses of ouabain in the Langendorff perfused rabbit heart.

Authors:  Eric E Morgan; Zhichuan Li; Cory Stebal; Aude Belliard; Glen Tennyson; Bijan Salari; Keith D Garlid; Sandrine V Pierre
Journal:  J Cardiovasc Pharmacol       Date:  2010-03       Impact factor: 3.105

5.  Landiolol does not enhance the effect of ischemic preconditioning in isolated rat hearts.

Authors:  Shuchun Yu; Takasumi Katoh; Hisako Okada; Hiroshi Makino; Soichiro Mimuro; Shigehito Sato
Journal:  J Anesth       Date:  2010-01-19       Impact factor: 2.078

6.  The impact of sex and myocardial ischemic preconditioning on immunohistochemical markers of acute myocardial infarction.

Authors:  K Scholl; R Huhn; St Ritz-Timme; F Mayer
Journal:  Int J Legal Med       Date:  2018-10-23       Impact factor: 2.686

7.  [Ischemic preconditioning in the aged heart--myocardial protective effect as compared with the mature heart].

Authors:  M Uematsu; M Okada
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-09

8.  [Does adenosine administration during the early reperfusion period affect ischemic preconditioning?].

Authors:  M Uematsu; M Okada
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-09

9.  Effects of postconditioning with N,N,N'N'-tetrakis-[2-pyridylmethyl]-ethylenediamine in isolated rat hearts.

Authors:  Joon Hong Kim; Joon Kim; Yong-Hyeon Park; Kook Jin Cheun; Young-Ho Jang
Journal:  Korean J Anesthesiol       Date:  2010-03-29

Review 10.  Preconditioning the human myocardium: recent advances and aspirations for the development of a new means of cardioprotection in clinical practice.

Authors:  D P Jenkins; S E Steare; D M Yellon
Journal:  Cardiovasc Drugs Ther       Date:  1995-12       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.